Specifically, the NKG2A+KIR2DL3+ and NKG2A+KIR2DL1+ NK cell subsets (referred to as NKG2A+KIR+) represent the most effective NK cells against AML [171]. This evidence concerns the gene KIR3DL1 and acute myeloid leukemia.